|
| Status |
Public on Sep 11, 2014 |
| Title |
MDA20194 (HG-U133A) |
| Sample type |
RNA |
| |
|
| Source name |
GBM tumor
|
| Organism |
Homo sapiens |
| Characteristics |
site: NA
gender: female
age: 55.7
survival: 158
censored: no
|
| Biomaterial provider |
MDA
|
| Extracted molecule |
total RNA |
| Extraction protocol |
RNA was isolated using Trizol and purified with Qiagen RNeasy columns
|
| Label |
biotin
|
| Label protocol |
Approximately 1-5 ug of total RNA was processed to produce biotynylated cRNA targets
|
| |
|
| Hybridization protocol |
Standard Affymetrix procedure
|
| Scan protocol |
Standard Affymetrix procedure
|
| Data processing |
R/Bioconductor RMA processing with custom CDF v.18.0.0, ENTREZG
|
| |
|
| Submission date |
Sep 11, 2014 |
| Last update date |
Sep 11, 2014 |
| Contact name |
Joseph Costello |
| Organization name |
UCSF
|
| Department |
NeuroSurgery
|
| Street address |
1450 3rd St
|
| City |
San Francisco |
| State/province |
CA |
| ZIP/Postal code |
94158 |
| Country |
USA |
| |
|
| Platform ID |
GPL19184 |
| Series (1) |
| GSE61335 |
AKT pathway genes define 5 prognostic subgroups in glioblastoma |
|
